NCT03912831 2023-12-26Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ CancersGilead SciencesPhase 1 Terminated8 enrolled 13 charts
NCT04596033 2022-07-15TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyGenocea Biosciences, Inc.Phase 1 Terminated49 enrolled
NCT00329368 2012-03-09Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic CancerEndocytePhase 1 Completed13 enrolled
NCT00485563 2012-03-08A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell CarcinomaEndocytePhase 2 Terminated12 enrolled